Response to oral supplementation in copper deficiency myeloneuropathy
Neurological manifestations due to copper deficiency include ataxic myeloneuropathy that resembles subacute combined degeneration due to B12 deficiency. We report our experience in the treatment of 10 patients with copper deficiency myeloneuropathy and conclude that copper supplementation leads to stabilization rather than improvement in the neurological deficits. © 2008 by Lippincott Williams & Wilkins.
Journal of Clinical Neuromuscular Disease
Digital Object Identifier (DOI)
Kelkar, Praful; Chang, Shereen; and Muley, Suraj A., "Response to oral supplementation in copper deficiency myeloneuropathy" (2008). Neurology Articles. 498.